Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.

Source:http://linkedlifedata.com/resource/pubmed/id/9222642

Download in:

View as

General Info

PMID
9222642